There was a significant decrease in the abundance of CD49d on the CD4+ Tem population in glioblastoma compared to blood samples, and a significant increase in CD49d gMFI on CD4+ Tregs in glioblastoma (Supplementary Figure 5A). This evidence concerns the gene CD4 and glioblastoma.